ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

9,001Medicare Part D Prescriptions Filled, Including Refills

Rank: 23 out of 586

$530K Total Retail Price of All Prescriptions

Rank: 19 out of 586

402 Patients Receiving at Least One Drug in Part D
75%Patients 65 Years and Older
42% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Utah
Lower avg

Schedule Two
Controlled Substances

9% of this provider’s 402 patients filled at least one prescription for a schedule two drug, compared to an average of 6%.

Schedule Three
Controlled Substances

19% of this provider’s 402 patients filled at least one prescription for a schedule three drug, compared to an average of 12%.

Risky Drugs to Seniors

1% of this provider’s 6,324 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

22% of this provider’s prescriptions were for brand-name drugs, compared to an average of 22%.

Prescription Price

$59 was the average price of a prescription from this provider, compared to $57 among peers.

Prescriptions per Patient

22 is the average number of prescriptions (including refills) per patient, compared to an average of 16.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Utah
OMEPRAZOLE 456 265 1 3
SIMVASTATIN 431 349 2 1
LISINOPRIL 411 293 3 4
METFORMIN HCL 333 247 4 6
HYDROCODONE-ACETAMINOPHEN 322 150 S3 5 5
LEVOTHYROXINE SODIUM 267 220 6 2
FLUTICASONE PROPIONATE 218 152 7 28
HYDROCHLOROTHIAZIDE 205 155 8 10
ZOLPIDEM TARTRATE 189 117 9 8
AMLODIPINE BESYLATE 174 136 10 7
CITALOPRAM HBR 165 127 11 12
ALENDRONATE SODIUM 163 151 12 23
PRAVASTATIN SODIUM 152 118 13 22
GABAPENTIN 141 104 14 11
METOPROLOL SUCCINATE 139 111 15 19
TRAMADOL HCL 134 73 16 15
ATORVASTATIN CALCIUM 132 120 17 17
SERTRALINE HCL 126 101 18 21
FENOFIBRATE 121 97 19 39
CARVEDILOL 114 84 20 30
POTASSIUM CHLORIDE 114 86 20 14
LOSARTAN POTASSIUM 113 89 22 18
FUROSEMIDE 105 79 23 9
WARFARIN SODIUM 98 74 24 13
PROAIR HFA 91 31 25 58
TRAZODONE HCL 80 42 26 20
LISINOPRIL-HYDROCHLOROTHIAZIDE 78 68 27 16
TAMSULOSIN HCL 76 42 28 27
SPIRIVA 74 33 29 81
GLIMEPIRIDE 74 62 29 38
LANTUS 67 34 31 33
CYMBALTA 66 30 32 29
CLOPIDOGREL 64 47 33 71
SYMBICORT 63 23 34 214
ALLOPURINOL 62 53 35 35
ADVAIR DISKUS 60 42 36 59
JANUVIA 58 43 37 74
LOSARTAN-HYDROCHLOROTHIAZIDE 58 47 37 31
DONEPEZIL HCL 57 49 39 40
CELEBREX 57 42 39 44
OXYBUTYNIN CHLORIDE 54 29 41 83
DIOVAN 52 49 42 72
LANTUS SOLOSTAR 50 28 43 80
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 1, 2008.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.